Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001268707 | SCV001447835 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV002283538 | SCV002572521 | likely pathogenic | Achromatopsia 2 | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). It is predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region. The variant has been reported to be associated with CNGA3-related disorder (ClinVar ID: VCV000987366). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |